A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the German Cancer Research Center (DKFZ), the Hector Institute für Translational ...

The Rice lab of bioengineer Gang Bao and collaborators at Baylor College of Medicine have developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the ...

A FIT and healthy woman assumed an ache in her chest was caused by an ill-fitting bra – but it was something far more ...

Q4 2024 Management View CEO Brian Goff highlighted the company's strategic focus on expanding the Pyrukynd franchise, with significant growth expected from the potential approval and launch in ...

A research team has identified the transcription factor Lhx2 (LIM homeobox protein 2) as a key regulator in hepatic stellate ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

Feb. 6, 2025 — The research found that heavy drinkers with either diabetes, high blood pressure or a high waist circumference are as much as 2.4 times more likely to develop advanced liver ...

A Lifesaving Innovation in the Fight Against Acute Liver Failure A revolutionary medical breakthrough is offering new hope in ...

The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.

It has two lobes (sections). The liver is made up mainly of cells called hepatocytes. It also has other types of cells, including cells that line its blood vessels and cells that line small tubes in ...

The leading cause is a viral infection with hepatitis B or C virus. The most frequent liver cancers are hepatocellular carcinoma and hepatoblastoma (formed by immature liver cells).

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.